New radiation cocktail aims to cut prostate cancer treatment time
NCT ID NCT01655836
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This phase 1 trial tests a combination of two radiation techniques for men with intermediate risk prostate cancer. First, a high dose of radiation is placed inside the prostate for 10-20 minutes (brachytherapy), followed by three weeks of highly targeted external radiation (SBRT). The goal is to see if this shorter treatment plan is safe and tolerable. 42 men are enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiation therapy (high dose rate brachytherapy and stereotactic body radiation therapy)
- What this could lead to
- If successful, this could lead to a shorter, more precise radiation treatment option for intermediate risk prostate cancer with fewer side effects.
- What could go wrong
- This is an early phase 1 trial with only 42 participants, focused on safety. It may not show better outcomes than standard treatments, and there are risks of radiation-related side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE PROSTATE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- Glowing dye could light up hidden lymph nodes in prostate cancer surgery
- AI coaches doctors on cancer risk talks